Filing Details
- Accession Number:
- 0001213900-20-015029
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-06-15 17:14:03
- Reporting Period:
- 2020-06-11
- Accepted Time:
- 2020-06-15 17:14:03
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1763950 | Lantern Pharma Inc. | LTRN | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1393516 | Jeffrey D Keyser | C/O Lantern Pharma Inc. 1920 Mckinney Avenue, 7Th Floor Dallas, TX 75201 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-06-11 | 10,000 | $15.00 | 10,000 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- The 10,000 shares of common stock were purchased by the Reporting Person at the offering price $15.00 per share for a total purchase price of $150,000, in connection with Issuer's initial public offering which closed on June 15, 2020. The Reporting Person received notification of the order on June 11, 2020.
Billionaire Hedge Funds
